Bank of Montreal and Bank of Nova Scotia are up considerably in the past six months. Is one headed higher in 2025? The post ...
Let's dive into where Canadian Tire (TSX:CTC.A) could be headed in 2025, and if this is a stock worth considering right now.
Goeasy stock still looks like a winner, so why is the stock price down below $170? The post Should You Buy Goeasy Stock While ...
The Nifty 50 index has fallen for eight consecutive sessions, dropping 3.4% amid trade war concerns. Sumeet Bagadia ...
Buy the dip as gold nears $3k? 2025 investment opportunities outlook and analysis The post Kinross Gold: Buy, Sell, or Hold ...
Stocks like Enbridge provide significant dividend income, which is ideal for tax-savings within your TFSA. The post ...
As consumer spending remains robust, the airline industry and this Canadian flag-carrying airline, in particular, are ...
These three ETFs are a match made in dividend heaven, especially when put into a TFSA! The post 3 Canadian ETFs to Buy and Hold in a TFSA for a Lifelong Relationship appeared first on The Motley Fool ...
Julie Cooke, Chief Human Resources Officer at Neurocrine Biosciences Inc. (NASDAQ:NBIX), recently sold company shares valued at $181,129. The transactions, executed on February 13, 2025, involved the ...
Stephen A. Sherwin, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), a $11.4 billion biopharmaceutical company with strong financials and a healthy current ratio of 3.4, sold 13,831 shares of ...
Telus (TSX:T) stock stands out as an interesting bargain as the yield approaches 8% again. The post A Bargain Dividend Stock ...
Officer of Neurocrine Biosciences Inc. (NASDAQ:NBIX), executed a series of stock transactions earlier this month, according to a recent SEC filing. The transactions come as the $11.4 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results